Imagion Biosystems Ltd has released a press release.
Ph2 Manufacturing & Imaging Optimisation Activities Commence
Filed with ASX ·
6ix hasn’t read this filing yet.
Imagion Biosystems Ltd. on 6ix
Story so far
Earlier from Imagion Biosystems
- Appendix 4D and Half-yearly Financial Report
- IBX Secures Firm Commitments for A$3.5m Capital Raising
- Trading Halt
- Appendix 4C and Quarterly Activities Report - June 2025
- Imagion MagSense Breast Cancer Program Phase 2 Trial Update
Later from Imagion Biosystems
- Imagion Biosystems HER2 Breast Cancer Program Update
- Appendix 4C and Quarterly Activities Report - September 2025
- Positive Results Received from WSU on MagSense Dosage
- Positive Final WSU Trial Results To Support IND Submission
- Mercer Convertible Securities Conversion and Amendment
Follow Imagion Biosystems into a list and get an email when it puts out news.
Follow Imagion Biosystems